Patents by Inventor Bernhard Kutscher

Bernhard Kutscher has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5965582
    Abstract: The N-benzylindole- and benzopyrazole derivatives of the general formula 1 ##STR1## possess anti-asthmatic, anti-allergic, anti-inflammatory and immunomodulating effect and are suitable for the preparation of medicaments.
    Type: Grant
    Filed: May 12, 1997
    Date of Patent: October 12, 1999
    Assignee: ASTA Medica Aktiengesellschaft
    Inventors: Guillaume Lebaut, Fabienne Fouchard, Bernhard Kutscher, Peter Emig, Ilona Fleischhauer, Jurgen Schmidt, Stefan Szelenyi
  • Patent number: 5959115
    Abstract: A process for preparation of pure flupertine maleate and the pure A crystalline form of flupertine maleate by the use of water soluble alcohols during synthesis and/or purification.
    Type: Grant
    Filed: April 23, 1998
    Date of Patent: September 28, 1999
    Assignee: ASTA Medica Aktiengesellschaft
    Inventors: Alfred Olbrich, Peter Emig, Bernhard Kutscher, Karl-Friedrich Landgraf, Siegfried Pauluhn, Hans Stange
  • Patent number: 5958906
    Abstract: Phospholipid derivatives containing higher elements of the Vth main group (P, As, Sb, Bi), their method of preparation and antineoplastic and antimicrobially active medications that can be prepared from the phospholipid derivatives.
    Type: Grant
    Filed: May 7, 1997
    Date of Patent: September 28, 1999
    Assignee: ASTA-Medica Aktiengesellschaft
    Inventors: Gerhard Nossner, Jurij Stekar, deceased, Peter Hilgard, Bernhard Kutscher, Jurgen Engel
  • Patent number: 5942493
    Abstract: New LH-RH antagonists are disclosed, in particular peptidomimetics and peptides modified in a side chain, their salts with pharmaceutically acceptable acids and a process for preparing these LH-RH antagonists and their salts. The disclosed peptides represent analogues of the luteinising hormone releasing hormone (LH-RH). The disclosed compounds have a high antagonistic power and are free of undesirable side effects, in particular edematogenic effects.
    Type: Grant
    Filed: May 28, 1998
    Date of Patent: August 24, 1999
    Assignee: ASTA Medica Aktiengesellschaft
    Inventors: Bernhard Kutscher, Michael Bernd, Thomas Beckers, Thomas Klenner, Peter-Paul Emig, Patricia-Marie Charpentier
  • Patent number: 5914425
    Abstract: The invention relates to novel modifications of the compound 2-amino-4-(4-fluorobenzylamino)-1-ethoxy-carbonylaminobenzene of the formula I ##STR1## processes for their preparation and their use in pharmaceutical compositions.
    Type: Grant
    Filed: January 9, 1998
    Date of Patent: June 22, 1999
    Assignee: ASTA Medica Aktiengesellschaft
    Inventors: Peter Meisel, Karl-Friedrich Landgraf, Jurgen Schafer, Wilfried Thiel, Matthias Rischer, Alfred Olbrich, Bernhard Kutscher
  • Patent number: 5770574
    Abstract: Long-chain, unbranched alkylamides of the general formulaCH.sub.3 --(CH.sub.2).sub.n N--NH--Rin which n=11-20 and R=amino acid, its D- and L-enantiomers, di- and tripeptides, forms derived by N-protective groups, and terminal ethyl esters as well as its physiologically compatible salt forms as active pharmaceutical substances with anti-proliferative and anti-inflammatory properties.
    Type: Grant
    Filed: June 19, 1997
    Date of Patent: June 23, 1998
    Assignee: ASTA Medica Aktiengesellschaft
    Inventors: Bernhard Kutscher, Michael Bernd, Heinz Grossmann, Maria Kick, Jurgen Arp, Manfred Lieflander, Jurgen Engel, Rainer Voegeli
  • Patent number: 5760221
    Abstract: This disclosure describes two technical procedures for the high-yield synthesis of heterocyclic seven-membered ring-systems by Dieckmann-condensation avoiding usual dilution techniques and long reaction times. Thus, it significantly increases the overall yields of the pharmaceutically active ingredients azelastine and flezelastine, whose synthesis, starting from these seven-membered heterocyclic rings, is reported elsewhere. Yields range from 80-89%, avoiding waste and increasing economics of the synthesis.
    Type: Grant
    Filed: December 19, 1994
    Date of Patent: June 2, 1998
    Assignee: ASTA Medica Aktiengesellschaft
    Inventors: Alfred Olbrich, Jurgen Engel, Bernhard Kutscher, Roland Moller
  • Patent number: 5747534
    Abstract: Cis-?trans-1,2-cyclobutanebis (methylamine)-N,N'!-?(2S)-lactate-O.sup.1,O.sup.2)-platinum (II) trihydrate (lobaplatin trihydrate) and its preparation.
    Type: Grant
    Filed: September 16, 1996
    Date of Patent: May 5, 1998
    Assignee: Asta Medica AG
    Inventors: Eckhard Gunther, Jens-Peter Wulf, Jurgen Engel, Bernhard Kutscher
  • Patent number: 5723463
    Abstract: The invention relates to novel pyrido?3,2-e!pyrazinones, processes for their preparation and their pharmaceutical use.The compounds have anti-asthmatic and anti-allergic effects.
    Type: Grant
    Filed: March 25, 1996
    Date of Patent: March 3, 1998
    Assignee: ASTA Medica Aktiengesellschaft
    Inventors: Norbert Hofgen, Thomas Buchner, Ute Achterrath-Tuckermann, Stefan Szelenyi, Bernhard Kutscher
  • Patent number: 5637577
    Abstract: Phospholipid derivatives containing higher elements of the Vth main group (P, As, Sb, Bi), their method of preparation and antineoplastic and antimicrobially active medications that can be prepared from the phospholipid derivatives.
    Type: Grant
    Filed: April 14, 1995
    Date of Patent: June 10, 1997
    Assignee: Asta Medica Aktiengesellschaft
    Inventors: Gerhard Nossner, Jurij Stekar, Peter Hilgard, Bernhard Kutscher, Jurgen Engel
  • Patent number: 5556836
    Abstract: Use of 7-amino-L-glycero-L-gulo-2,6-anhydro-7-desoxy-heptonic acid and 2-benzoxycarbonylamino-0.sup.1 -methyl-2-desoxy-.beta.-glucopyranuronic acid, their derivatives and the enantiomorphous compounds for incorporation and for manufacture in pharmacologically active peptide hormones.
    Type: Grant
    Filed: November 1, 1994
    Date of Patent: September 17, 1996
    Assignee: Asta Medica Aktiengesellschaft
    Inventors: Erich G. Roedern, Horst Kessler, Bernhard Kutscher, Michael Bernd, Thomas Klenner
  • Patent number: 5556856
    Abstract: Phthalazinone derivatives and their optical isomers are used as medications to combat heart rhythm disturbances, to combat pain and to break through multi-drug resistance.
    Type: Grant
    Filed: April 4, 1995
    Date of Patent: September 17, 1996
    Assignee: Asta Medica Aktiengesellschaft
    Inventors: Jurgen Engel, Bernhard Kutscher, Ilona Fleischhauer, Stefan Szelenyi, Peter Metzenauer, Ulrich Werner
  • Patent number: 5539107
    Abstract: A process for the production of azophenothiazine derivatives having either of the following structures: ##STR1## where X and Y include alkyl, alkoxy, halogen, hydrogen, carboxy, or carboxy alkyl substituents. These compounds are precursors to pharmaceutically active compounds such as pipacetate. The process involves the reaction of a 2-chloropyridine with a 2-mercaptoaniline or a dimer of 2-(2-mercaptophenylamino)pyridine in an inert solvent, e.g., .gradient.-methylpyrolidone in the presence of an oxidizing agent, e.g., performic acid.
    Type: Grant
    Filed: April 17, 1995
    Date of Patent: July 23, 1996
    Assignee: ASTA Medica Aktiengesellschaft
    Inventors: Bernhard Kutscher, Hans-Reinhold Dieter
  • Patent number: 5464838
    Abstract: 6-amino carboxylic acid derivatives having antiasthmatic and antiallergic properties which can be used for the preparation of medicaments. The compounds have the formula: ##STR1## wherein R.sub.1 and R.sub.2 represent hydrogen, a straight-chain or branched alkyl radical with 1-6 carbon atoms, benzyl or phenylethyl, R.sub.3 represents hydrogen, a straight-chain or branched alkyl radical with 1-6 carbon atoms or benzyl, X represents hydrogen, halogen, C.sub.1 -C.sub.6 -alkyl or C.sub.1 -C.sub.6 -alkoxy, Y.sub.1 and Y.sub.2 represent hydrogen, halogen, C.sub.1 -C.sub.6 -alkyl or C.sub.1 -C.sub.6 -alkoxy, where m, n and o can assume the values from 0-4.
    Type: Grant
    Filed: March 4, 1993
    Date of Patent: November 7, 1995
    Assignee: Asta Medica Aktiengesellschaft
    Inventors: Bernhard Kutscher, Georg Niebch, Ilona Fleischhauer, Jurgen Engel, Ute Achterrath-Tuckermann, Stefan Szelenyi
  • Patent number: 5449798
    Abstract: Phospholipid derivatives containing higher elements of the Vth main group (P, As, Sb, Bi), their method of preparation and antineoplastic and antimicrobially active medications that can be prepared from the phospholipid derivatives.
    Type: Grant
    Filed: September 22, 1993
    Date of Patent: September 12, 1995
    Assignee: Asta Medica Aktiengesellschaft
    Inventors: Gerhard Nossner, Jurij Stekar, Peter Hilgard, Bernhard Kutscher, Jurgen Engel
  • Patent number: 5446148
    Abstract: 6-aza-benzo[b]-phenothiazine derivatives having the formula, ##STR1## wherein X and Y can be any of hydrogen, lower alkyl, lower haloalkyl, carboxyl or carboxy alkyl are obtained through a reaction of 2-quinioline derivatives having the formula ##STR2## with a suitable 2-mercaptoaniline derivatives or dimers thereof under oxidative or free radical conditions.The 6-aza-benzo[b]-phenothiazine derivative are valuable precursors for pharmaceutically active substances such as pipacetate, isothioperdyl and prothiperdyl.
    Type: Grant
    Filed: March 9, 1994
    Date of Patent: August 29, 1995
    Assignee: Asta Medica Aktiengesellschaft
    Inventors: Bernhard Kutscher, Hans-Reinhold Dieter
  • Patent number: 5405847
    Abstract: Novel compounds of the formula ##STR1## where the phenyl ring can also contain a nitrogen atom instead of a CH group, R.sub.1 is C.sub.2 -C.sub.6 -alkenyl, C.sub.2 -C.sub.6 -alkynyl, hydroxy, C.sub.1 -C.sub.6 -alkoxy, C.sub.3 -C.sub.6 -alkenyloxy, C.sub.3 -C.sub.6 -alkynyloxy, C.sub.2 -C.sub.6 -alkanoyloxy, benzoyloxy, morpholinocarbonyloxy, C.sub.1 -C.sub.6 -alkyloxycarbonyloxy, C.sub.1 -C.sub.6 -alkylaminocarbonyloxy, C.sub.1 -C.sub.6 -dialkylaminocarbonyloxy or the group -Alk-A, where Alk represents C.sub.1 -C.sub.6 -alkyl, C.sub.2 -C.sub.6 -hydroxyalkyl or C.sub.3 -C.sub.6 -cycloalkyl and the symbol A represents hydrogen or other substituents.R.sub.2, R.sub.3 and R.sub.4 represent various substituents, where R.sub.1 may also be hydrogen, when R.sub.2 is the group ##STR2## and R.sub.5 represents phenyl, C.sub.1 -C.sub.4 -alkoxyphenyl or diphenylmethyl and R.sub.3 and R.sub.4 are hydrogen and their salts. The compounds provide anti-allergic, anti-asthmatic, anxiolytic and hypotensive effects.
    Type: Grant
    Filed: August 24, 1993
    Date of Patent: April 11, 1995
    Assignee: Asta Medica Aktiengesellschaft
    Inventors: Hans-Reinhold Dieter, Jurgen Engel, Karl-Heinz Klingler, Bernhard Kutscher, Stefan Szelenyi, Ute Achterath-Tuckermann, Jurgen Schmidt, Peter Metzenauer
  • Patent number: 5384330
    Abstract: Pharmacologically active 1,2,4-triaminobenzene derivatives of the General Formula I: ##STR1## where the symbols R1' R2' R3' R4' R5' Ar and Alk have the following meanings:where the symbols R.sub.1, R.sub.2, R.sub.3, R.sub.4, R.sub.5, Ar and Alk have the following meanings:R.sub.1 : hydrogen, C.sub.1 -C.sub.6 -alkyl, C.sub.2 -C.sub.6 -alkanoyl or the radical Ar;R.sub.2 : hydrogen or C.sub.1 -C.sub.6 -alkyl;R.sub.3 : C.sub.1 -C.sub.6 -alkoxy, NH.sub.2, C.sub.1 -C.sub.6 -alkylamino, C.sub.1 -C.sub.6 -dialkylamino, amino substituted by the radical Ar, C.sub.1 -C.sub.6 -alkyl, C.sub.2 -C.sub.6 -alkenyl, C.sub.2 -C.sub.6 -alkynyl, the radical Ar or the radical ArO--;R.sub.4 : hydrogen, C.sub.1 -C.sub.6 -alkyl or the radical Ar;R.sub.5 : hydrogen or C.sub.1 -C.sub.6 -alkyl or the radical Ar;Alk: a straight or branched alkylene group containing 1-9 carbon atoms, which can also be substituted by the radical Ar.
    Type: Grant
    Filed: January 8, 1993
    Date of Patent: January 24, 1995
    Assignee: Asta Medica Aktiengesellschaft
    Inventors: Hans-Reinhold Dieter, Jurgen Engel, Bernhard Kutscher, Emanuel Polymeropoulos, Stefan Szelenyi, Bernd Nickel
  • Patent number: 5354750
    Abstract: Pharmacologically active compounds of the General Formula ##STR1## where X is oxygen or sulphur and the radical R represents a quinuclidyl radical, an C.sub.1 -C.sub.6 -alkyl radical, a phenyl radical, a pyridyl radical, a phenyl or pyridyl radical substituted by the radicals R.sub.1, R.sub.2, and/or R.sub.3, a C.sub.1 -C.sub.6 -alkyl radical substituted by pyridyl or alkylpyridyl or a C.sub.1 -C.sub.6 -alkyl radical substituted by phenyl, where each phenyl radical may also be substituted by the radicals R.sub.1, R.sub.2 and/or R.sub.3 and the radicals R.sub.1, R.sub.2 and R.sub.3 are the same or different and represent hydrogen, halogen, trihalogenmethyl, C.sub.1 -C.sub.6 -alkyl, C.sub.1 -C.sub.6 -alkoxy, carboxy, Carb-C.sub.1 -C.sub.6 -alkoxy, amino, C.sub.1 -C.sub.6 -alkylamino, C.sub.1 -C.sub.6 -dialkylamino, C.sub.1 -C.sub.6 -trialkylamino, C.sub.2 -C.sub.6 -alkanoylamino, or C.sub.2 -C.sub.
    Type: Grant
    Filed: October 20, 1992
    Date of Patent: October 11, 1994
    Assignee: Asta Medica Aktiengesellschaft
    Inventors: Gerhard Scheffler, Ilona Fleischhauer, Bernhard Kutscher, Jurgen Engel, Stefan Szelenyi, Ulrich Werner
  • Patent number: 5219866
    Abstract: Octadecyl-[2-(N-methylpiperidino)-ethyl]-phosphate and a process for its preparation. This compound is useful for the treatment of cancer.
    Type: Grant
    Filed: July 1, 1992
    Date of Patent: June 15, 1993
    Assignee: Asta Medica AG
    Inventors: Wolfgang Schumacher, Jurgen Engel, Gerhard Nossner, Bernhard Kutscher, Jurij Stekar, Peter Hilgard